Fact check
“The FDA’s 2021 rule made it impossible to issue orders on the vast majority of applications within 180 days.”
Reasoning
The Reason.com article reports that Helix et al. argue the FDA's 2021 rule prevented the agency from issuing orders on most applications within the statutory 180‑day deadline, aligning with the claim. No contradictory evidence is provided.
On confidence: The claim is directly supported by a secondary source quoting experts (Helix et al.) who state the 2021 rule made timely orders impossible.
Important context
The evidence is a secondary report summarizing expert analysis, not the original FDA rule text. The claim pertains to the practical effect of the rule as interpreted by Helix et al.
Evidence
Supporting (2)
- Tier 3 — Secondary reportingThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
must submit "such other information relevant to the subject matter" that HHS "may require." The FDA's 2021 rule "made it impossible for the FDA to issue orders on the vast majority of [applications] within 180 days," Helix et al. argue. It…
- Tier 3 — Secondary reportingThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
regulatory authority over tobacco products. That law "expressly requires the FDA to authorize the marketing of new tobacco products (including alternatives to cigarettes) as 'appropriate for the protection of the public health,'" Helix et…
Limitations
The source is a secondary news article; the original FDA rule or direct statements from the agency are not cited, limiting verification to the reported expert opinion.
- Last verified:
- Oct 1, 2026, 4:41 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine ProductsReason · Jacob Sullum